FFGRX
Price
$25.27
Change
-$0.11 (-0.43%)
Updated
Oct 17 closing price
VSGIX
Price
$76.82
Change
-$0.27 (-0.35%)
Updated
Oct 17 closing price
Ad is loading...

FFGRX vs VSGIX

Header iconFFGRX vs VSGIX Comparison
Open Charts FFGRX vs VSGIXBanner chart's image
Emerald Growth Investor
Price$25.27
Change-$0.11 (-0.43%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index I
Price$76.82
Change-$0.27 (-0.35%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FFGRX vs VSGIX Comparison Chart
Loading...
VS
FFGRX vs. VSGIX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFGRX is a Buy and VSGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 36B vs. FFGRX (1.05B). VSGIX pays higher dividends than FFGRX: VSGIX (0.67) vs FFGRX (0.00). FFGRX was incepted earlier than VSGIX: FFGRX (13 years) vs VSGIX (24 years). FFGRX is a more actively managed with annual turnover of: 62.00 vs. VSGIX (19.00). FFGRX has a lower initial minimum investment than VSGIX: FFGRX (2000) vs VSGIX (5000000). FFGRX (32.12) and VSGIX (30.69) have marching annual gain over last year. VSGIX return over 5 years is better than : 50.13 vs. FFGRX (5.88).
FFGRXVSGIXFFGRX / VSGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years24 years-
Gain YTD14.79313.124113%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.05B36B3%
Annual Yield % from dividends0.000.67-
Returns for 1 year32.1230.69105%
Returns for 3 years-27.48-5.02547%
Returns for 5 years5.8850.1312%
Returns for 10 years45.21140.4632%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KLCSX24.540.09
+0.37%
Federated Hermes Kaufmann Large Cap R6
ENHRX10.890.02
+0.18%
Cullen Enhanced Equity Income Retail
ITHVX59.640.05
+0.08%
Hartford Capital Appreciation R6
ALCBX13.42N/A
N/A
ALPS/Smith Balanced Opportunity C
MSEPX21.41-0.12
-0.56%
Morgan Stanley Inst Emerging Mkts C